Post COVID-19 Neurological Complications; a Meta-analysis

Overview

Journal Ann Med Surg (Lond)

Publisher Wolters Kluwer

Specialty Medical Education

Date 2022 Mar 9

PMID 35261766

Authors

Jaafar Omer Ahmed

Shwan Abdubakr Ahmad

Marwan Nasih Hassan

Fahmi H Kakamad

Rawezh Q Salih

Berwn A Abdulla

Fattah Hama Rahim Fattah

Shvan H Mohammed

Razhan K Ali

Abdulwahid M Salih

Affiliations

Soon will be listed here.

Abstract

Introduction: Despite numerous studies regarding neurological manifestations and complications of COVID-19, only a few cases of neurological consequences following complete recovery from SARS-CoV-2 infection have been described.

Objectives: The current study aims to present a quantitative meta-analysis of published studies regarding the post-infectious neurological complications of COVID-19.

Data Sources: The Web of Science, PubMed, MEDLINE on OVID, and Google scholar were searched for English-language researches published after January 1, 2020.

Result: The review of the literature revealed 60 cases - of which 40 (66.7%) cases were male, and 18 (30%) were female. The average age was 44.95 years. Overall, 17 (28.3%) patients had comorbid conditions. Twenty-four (40%) patients were hospitalized during an active COVID-19 infection. The average interval from the COVID-19 infection to the onset of neurological sequelae was 33.2 days. Guillain-Barre syndrome was the most commonly reported neurological condition (15, 25%).

Conclusion: Despite recovery from acute infection, the pandemic highlights the significance of ongoing, comprehensive follow-up of all COVID-19 patients - even those initially were believed to be asymptomatic.

Citing Articles

Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.

Teixeira-Vaz A, Paiva J Crit Care Sci. 2024; 36:e20240180en.

PMID: 39536209 PMC: 11554298. DOI: 10.62675/2965-2774.20240180-en.

COVID-19: Unveiling the Neuropsychiatric Maze-From Acute to Long-Term Manifestations.

Ariza D, Castellar-Visbal L, Marquina M, Rivera-Porras D, Galban N, Santeliz R Biomedicines. 2024; 12(6).

PMID: 38927354 PMC: 11200893. DOI: 10.3390/biomedicines12061147.

Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.

de Havenon A, Callaghan B, Xu Y, Connor M, Hill C, Ney J Neurology. 2024; 102(8):e209248.

PMID: 38507675 PMC: 11383855. DOI: 10.1212/WNL.0000000000209248.

Unmasking the long-term effects: unravelling neuropsychiatric and neurological consequences of COVID-19.

Tariq M, Mahak F, Kumar R, Kumar A, Kumar A, Khan J Ann Med Surg (Lond). 2024; 86(3):1490-1495.

PMID: 38463084 PMC: 10923314. DOI: 10.1097/MS9.0000000000001624.

Unveiling the Clinical Spectrum of Post-COVID-19 Conditions: Assessment and Recommended Strategies.

Assiri A, Alamaa T, Elenezi F, Alsagheir A, Alzubaidi L, TIeyjeh I Cureus. 2024; 16(1):e52827.

PMID: 38406111 PMC: 10884364. DOI: 10.7759/cureus.52827.

References

Inui R, Fujiwara S, Kohara N, Kawamoto M . Post COVID-19 Bilateral Facial Nerve Palsy. Intern Med. 2021; 61(2):241-243. PMC: 8851184. DOI: 10.2169/internalmedicine.8448-21. View

Kashyap H, Gupta V, Gupta A, Gupta T, Sharma S, Valjiyani S . Post-COVID Syndrome (MIS-C) with Refractory Status Epilepticus. Indian J Pediatr. 2021; 88(7):721. PMC: 8057941. DOI: 10.1007/s12098-021-03731-7. View

Maramattom B, Zachariah A, Meleth H, Zachariah Z, Mathew K . Post Covid-19 Guillain Barre Syndrome. Ann Indian Acad Neurol. 2021; 24(4):622-623. PMC: 8513986. DOI: 10.4103/aian.AIAN_853_20. View

Baghbanian S, Namazi F . Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report. Acta Neurol Belg. 2020; 121(6):1875-1876. PMC: 7500496. DOI: 10.1007/s13760-020-01497-x. View

Abolmaali M, Heidari M, Zeinali M, Moghaddam P, Ramezani Ghamsari M, Makiani M . Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series. J Clin Neurosci. 2020; 83:119-122. PMC: 7666532. DOI: 10.1016/j.jocn.2020.11.013. View

Appleberry H, Begezda A, Cheung H, Zaghab-Mathews S, Mainali G . Report of a Child With Febrile Status Epilepticus and Post-COVID Multi-System Inflammatory Syndrome. Child Neurol Open. 2021; 8:2329048X211027725. PMC: 8261841. DOI: 10.1177/2329048X211027725. View

Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini P . Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020; 417:117085. PMC: 7413162. DOI: 10.1016/j.jns.2020.117085. View

Diener H, Berlit P, Masjuan J . COVID-19: patients with stroke or risk of stroke. Eur Heart J Suppl. 2021; 22(Suppl Pt t):P25-P28. PMC: 7757708. DOI: 10.1093/eurheartj/suaa174. View

Kivanany P, Raviskanthan S, Mortensen P, Lee A . Antiaquaporin 4-Related Optic Neuritis and Myelitis Post-COVID-19 Infection. J Neuroophthalmol. 2021; 42(4):e571-e573. DOI: 10.1097/WNO.0000000000001347. View

10.

Ishaq H, Durrani T, Umar Z, Khan N, McCombe P, Ul Haq M . Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan. Front Neurol. 2021; 12:672524. PMC: 8215346. DOI: 10.3389/fneur.2021.672524. View

11.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021; 88:105906. DOI: 10.1016/j.ijsu.2021.105906. View

12.

Faber I, Brandao P, Menegatti F, de Carvalho Bispo D, Maluf F, Cardoso F . Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case. Mov Disord. 2020; 35(10):1721-1722. PMC: 7461093. DOI: 10.1002/mds.28277. View

13.

Yamamoto V, Bolanos J, Fiallos J, Strand S, Morris K, Shahrokhinia S . COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications. J Alzheimers Dis. 2020; 77(2):459-504. PMC: 7592693. DOI: 10.3233/JAD-200831. View

14.

Rass V, Beer R, Schiefecker A, Kofler M, Lindner A, Mahlknecht P . Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. 2021; 28(10):3348-3359. PMC: 8250725. DOI: 10.1111/ene.14803. View

15.

Rodrigues S, Oliveira R, Vilela P, Oliveira S . Spontaneous thrombosis of cerebral arteriovenous malformation post COVID-19. Neurol Sci. 2021; 42(12):4909-4911. PMC: 8441234. DOI: 10.1007/s10072-021-05598-0. View

16.

Nuzzo D, Vasto S, Scalisi L, Cottone S, Cambula G, Rizzo M . Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge. J Clin Med. 2021; 10(9). PMC: 8124354. DOI: 10.3390/jcm10091947. View

17.

Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A . Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series. J Neurol Sci. 2020; 420:117263. PMC: 7725056. DOI: 10.1016/j.jns.2020.117263. View

18.

Aasfara J, Hajjij A, Bensouda H, Ouhabi H, Benariba F . A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report. Pan Afr Med J. 2021; 38:30. PMC: 7955605. DOI: 10.11604/pamj.2021.38.30.27646. View

19.

Fotuhi M, Mian A, Meysami S, Raji C . Neurobiology of COVID-19. J Alzheimers Dis. 2020; 76(1):3-19. PMC: 7660990. DOI: 10.3233/JAD-200581. View

20.

Priftis K, Prior M, Meneghetti L, Mercogliano T, Bendini M . Alexia without agraphia in a post COVID-19 patient with left-hemisphere ischemic stroke. Neurol Sci. 2021; 42(6):2179-2181. PMC: 7994060. DOI: 10.1007/s10072-021-05211-4. View